Kris Ward joined the company in April 2022 and has played an instrumental role in the success of Landmark Bio. Under his leadership, the Business Development team built a strong pipeline and delivered 4-fold revenue increase year-over-year in an extremely challenging market. Prior to Landmark Bio, Kris was at Orchard Therapeutics for four years where he held various roles culminating with him leading Alliance Management and Business Operations. Prior to Orchard, Kris held Business Operations and Strategic Sourcing roles at Fresenius, Becton Dickinson (BD) and Hospira Pfizer. Kris has his MBA and an MS in Global Supply Chain Management from the Kelley School of Business at Indiana University, as well as a degree in Biological Sciences with a minor in Chemistry from Illinois State University.